Fortune Brands Chairman Norm Wesley Announces Retirement; To Be Succeeded by CEO Bruce Carbonari
                   
euroinvestor.co.uk
30-Sep-2008 3 related
        

Fortune Brands, Inc. (NYSE: FO): Norm Wesley, chairman of the board of Fortune Brands, Inc. (NYSE: FO), today announced that he will retire after more than two decades with the company and nearly nine years as chairman. Bruce Carbonari, currently president and chief executive officer, has been elected chairman and chief executive officer, effective October 1, 2008. Wesley, who also served as chief executive... [read full story]                    

Add Comment
There are also 3 related articles
View all news articles about*:
Banking Board Brands CEO Chairman Consumer COO Directors Finance Financial Fortune General Global Insurance Investing Issues Management Manufacturing Markets Office Products Senior Spirits Stock Supplies
*Newstin tag cloud displays all featured persons, associated organisations, related topics, regions and companies

View other selected articles:

                   

UK researchers help form the global debate around climate change

open.ac.uk
10 mins ago 558 related
        

Open University academics have won a prize in a prestigious international competition for short films on climate change. Dr David Humphreys, a senior lecturer in environmental policy at The Open University, visited Bangladesh...

add comment

INTERVIEW-Gruppo Coin sales in line with 2007 so far

reuters.com
01-Dec-2008 1 related
        

MILAN (Reuters) - Sales at Italian department store chain Gruppo Coin have so far been "exactly" in line with last year, with the weather having more of an impact than the recession, Chief Executive Stefano Beraldo said on Monday.

add comment
                   

Tapentadol Immediate Release Tablets Approved For The Treatment Of Moderate To Severe Pain By FDA

medicalnewstoday.com
28-Nov-2008
        

Grunenthal GmbH announces that the U.S. Food and Drug Administration (FDA) has approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain for adults 18 years and older. The New Drug...

add comment